You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TARS Exercise Disclosure
Goodrich Katherine · SEC Form 4 · Filed Jun 16, 2026
Exercise
Calculated transaction value
$0
Goodrich Katherine Director
TARS
Transaction date
Jun 12, 2026
Public filing date
Jun 16, 2026
Filing lag
Filed 4 days later
TARS daily price context
Close on/before transaction
$61.95
Jun 12, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 2,954 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0002044770-26-000004
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. TARS | Exercise | Jun 12, 2026 | Not reported |
| Tarsus Pharmaceuticals, Inc. TARS Current | Exercise | Jun 12, 2026 | $0 |